Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Srne Ltd Abg currently holds 1,500,000 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Srne Ltd Abg has been a net buyer of SRNE stock. They have purchased $5.0M and sold $0 worth of shares.
Srne Ltd Abg's most recent insider trade was on Apr 13, 2017, when they purchased 1,500,000 shares at $2.00 per share.
Srne Ltd Abg serves as Executive at Sorrento Therapeutics, Inc. (SRNE). They have executed 2 insider transactions totaling $5.0M over their tenure at the company.
Srne Ltd Abg holds the position of Executive at Sorrento Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Srne Ltd Abg has shown a buying trading pattern, with $5.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Srne Ltd Abg was on Apr 13, 2017, when they purchased $3.0M worth of SRNE shares. This transaction involved 1,500,000 shares at $2.00 per share.
Srne Ltd Abg currently owns 1,500,000 shares of Sorrento Therapeutics, Inc. (SRNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Srne Ltd Abg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Srne Ltd Abg has 2 Form 4 filings on record as an insider at Sorrento Therapeutics, Inc..
Set alerts for Srne Ltd Abg and 40,000+ other insiders.